News
Dagmar Führer PI in CANcer TARgeting (CANTAR) research network
The state government of North Rhine-Westphalia is funding the CANcer TARgeting (CANTAR) research network with 19.4 million euros.
The overall concept of CANTAR builds on the strategic bundling of highly complementary expertise in North Rhine-Westphalia. The aim of the project is to develop new chemical substances to specifically intercept oncogenic pathways and immune escape mechanisms in cancer.
The CANTAR research at UKE is based at the WTZ and hedaed by University Professor Dr. Christian Reinhardt, Director of the Clinic for Hematology and Stem Cell Transplantation at University Hospital Essen. LOCOTACT spokesperson Dagmar Führer is a PI in the CANTAR research network: "CANTAR aims to bridge the gap gap between basic research and translational clinical cancer research and we are proud to contribute to this relevant goal."
Astrid Westendorf follows LOCOTACT Spokesperson Dagmar Führer as Vice-Rector for Research and Early-Career Researchers
Since April 2018 LOCOTACT spokesperson Dagmar Führer was the Vice-Rector for Research and Early-Career Researchers ath the University of Duisburg-Essen.
From April 2022 on, Prof. Dr. Astrid Westendorf follows Dagmar Führer in this importiant function. We wish Prof. Westendorf all the best for this new task.
Four young scientists received LOCOTACT iRTG MD Fellowships 2022!
LOCOTACT at the 65th German Congress of Endocrinology (DGE) Annual Meeting
On Saturday, 19.03.2022, the LOCOTACT symposium was chaired by Professor Dagmar Führer-Sakel (Essen) and Professor Jens Mittag (Lübeck). During the symposium, our CRC/TR 296 members Dr. Helge Müller-Fielitz, (Lübeck), Professor Lars Möller (Essen), and Professor Henrik Oster (Lübeck) gave insights in their scientific research. LOCOTACT members were present in various sessions of the congress; among them PIs Dr. Steffen Mayerl (P19), Professor Joachim Spranger (P15), and iRTG students Nuria López Alcántara (P14), and Julia Maier (P12).
Prior to opening of the DGE annual meeting, Professor Dagmar Führer-Sakel was invited to give a statement in the online press conference. In this context, she gave our consortium a stage and presented the topics and aims of LOCOTACT to the attending journalists. You can access a record of the press conference here: DGE Congress press conference
Medical Tribune LOCOTACT
ERC Consolidator Grants for outstanding Scientific Work
Funding period extended - UMEA Clinician Scientist Program enters next round
The program "Excellence in Medicine: Clinician Scientist Academy of the University Medical Center Essen" (UMEA) will be funded by the German Research Foundation (DFG) with approximately 2.6 million euros for another three years.
Since 2018 UMEA is headed by LOCOTACT spokesperson Dagmar Führer, who is also Vice-Rector for Research and Early-Career Researchers at the University of Duisburg-Essen.
We congratulate for this great achievement.
Research Data Management in Medical and Biomedical Sciences
On 20 and 22 June 2022 (9:00 am - 12:30 pm) the INF project and the Research Data Services (RDS) of the University of Duisburg-Essen (https://www.uni-due.de/rds/) will jointly offer in cooperation with the ZB MED (https://www.zbmed.de/) a workshop on Research Data Management (RDM) in Medical and Biomedical Sciences in the CRC/TR 296 LOCOTACT. The workshop will provide a general introduction to the basics of RDM in addition to best practices, subject-specific requirements, and examples from the National Research Data Infrastructure (NFDI).
The two-day workshop will take place online and is intended for all-qualification-level (bio-)medical researchers, especially for PhD/MD students of the CRC/TR 296 LOCOTACT, postdocs and PIs are also welcome to join. The course will be taught in English.
LOCOTACT Lectures - Miguel López
We thank Prof. Miguel López for his fantastic talk entitled “Obesity Wars: A new hope, hypothalamic AMPK targeting”.
Prof. López gave insights in his work and his stunning findings about hypothalamic AMPK targeting in the context of obesity treatment. His research group “NeurObesity” is based in the Center for Research in Molecular Medicine and Chronic Diseases (CIMUS) at the University of Santiago de Compostela (USC), Spain.
We are curious about his future investigations and wish him a successful research year 2022.
Heike Heuer invited to Dutch Endocrine Meeting 2022
We are delighted about the invitation of Heike Heuer to the Dutch Endocrine Meeting 2022 in Noordwijkerhout, the Netherlands, on 03. and 04.02.2022.
On the second day of the Meeting, Heike Heuer held her talk on "Thyroid hormone transporters as cell-specific gate-keepters".